The treatment of African trypanosomiasis.
D000351:Africa, Eastern; D000354:Africa, Western; D000578:Amidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001152:Arsenicals / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D012008:Recurrence; D013498:Suramin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014227:Triazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014344:Trypanocidal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014353:Trypanosomiasis, African / Q000134:cerebrospinal fluid / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology
D000578:Amidines; D001152:Arsenicals; D014227:Triazines; D014344:Trypanocidal Agents; D013498:Suramin